585 Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1.
http://stke.sciencemag.org/content/8/397/ra98.abstract
584 The genomic landscape of response to EGFR blockade in colorectal cancer.
http://www.nature.com/nature/journal/v526/n7572/full/nature14969.html
583 Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.
http://www.nature.com/ncomms/2015/151007/ncomms9469/full/ncomms9469.html
582 Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis.
http://www.nature.com/ncb/journal/v17/n9/abs/ncb3218.html
581 Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.
http://www.cell.com/cell/abstract/S0092-8674(15)01025-9
580 Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival.
http://www.cell.com/cell/abstract/S0092-8674(15)01045-4
579 Detection of single amino acid mutation in human breast cancer by disordered plasmonic self-similar chain.
http://advances.sciencemag.org/content/1/8/e1500487
578 The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma.
http://stm.sciencemag.org/content/7/304/304ra143
577 Rhomboid domain containing 1 promotes colorectal cancer growth through activation of the EGFR signalling pathway.
http://www.nature.com/ncomms/2015/150824/ncomms9022/full/ncomms9022.html
576 Regional Nodal Irradiation in Early-Stage Breast Cancer.
http://www.nejm.org/doi/full/10.1056/NEJMoa1415340
575 Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met.
http://www.nature.com/nm/journal/v21/n8/abs/nm.3641.html
574 Injectable cryogel-based whole-cell cancer vaccines.
http://www.nature.com/ncomms/2015/150812/ncomms8556/full/ncomms8556.html
573 Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion.
http://stke.sciencemag.org/content/8/389/ra80.abstract
572 Gram-scale synthesis of coordination polymer nanodots with renal clearance properties for cancer theranostic applications.
http://www.nature.com/ncomms/2015/150806/ncomms9003/full/ncomms9003.html
571 Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription.
http://www.nature.com/ncomms/2015/150806/ncomms8930/full/ncomms8930.html
570 Comprehensive genomic profiles of small cell lung cancer.
http://www.nature.com/nature/journal/v524/n7563/full/nature14664.html
569 A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models.
http://www.nature.com/ncomms/2015/150804/ncomms8939/full/ncomms8939.html
568 Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice.
http://stm.sciencemag.org/content/7/298/298ra117
567 Loss of ATM accelerates pancreatic cancer formation and epithelial–mesenchymal transition.
http://www.nature.com/ncomms/2015/150729/ncomms8677/full/ncomms8677.html
566 Cancer in the parasitic protozoans Trypanosoma brucei and Toxoplasma gondii.
http://www.pnas.org/content/112/29/8835.abstract
|
